PEP02
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for PEP02, covering 2012-03-02 to 2019-09-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer [Phase 2]